BRONCOPULMIN PLUS TMPS ORAL POWDER

국가: 오스트레일리아

언어: 영어

출처: APVMA (Australian Pesticides and Veterinary Medicines Authority)

지금 구매하세요

환자 정보 전단 (PIL)

20-06-2017

제품 특성 요약 (SPC)

20-06-2017

안전 데이터 시트 (SDS)

19-06-2000

유효 성분:

CLENBUTEROL HYDROCHLORIDE; TRIMETHOPRIM; SULFADIAZINE

제공처:

JUROX PTY LIMITED

INN (International Name):

clenbuterol HCl(21.44ug/g)+sulfadiazine(335mg/g)+trimethoprim(67mg/g)

약제 형태:

ORAL POWDER, PRE-MIX

구성:

CLENBUTEROL HYDROCHLORIDE ANILIDE/ANILINE Active 21.44 ug/g; TRIMETHOPRIM PYRIMIDINE Active 67.0 mg/g; SULFADIAZINE SULFANYL Active 335.0 mg/g

패키지 단위:

400g; 500g

수업:

VM - Veterinary Medicine

치료 그룹:

치료 영역:

RESPIRATORY + ANTIBIOTIC

치료 징후:

제품 요약:

Poison schedule: 4; Withholding period: WHP: Do not use in horses that may be slaughtered for human consumption.; Host/pest details: HORSE: [ANTIBIOTIC - ANTI-INFECTIVE, BRONCHODILATOR]; Poison schedule: 4; Withholding period: ; Host/pest details: HORSE: [ANTIBIOTIC - ANTI-INFECTIVE, BRONCHODILATOR]; Oral bronchodilator and antibacterial for respiratory disease in horses.DO NOT USE in food producing animals. Should not be used in horses during the last 14 days of digestion as uterine contractions may be prevented

승인 상태:

Registered

승인 날짜:

2023-07-01

제품 특성 요약

BRONCOPULMIN PLUS TMPS ORAL POWDER
Page 1 of 6
continued
ISSUED:
12 FEBRUARY 2013
SAFETY DATA SHEET
SECTION 1: IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
PRODUCT NAME:
BRONCOPULMIN PLUS TMPS ORAL POWDER
PRODUCT CODE:
501805 (500 g)
RECOMMENDED USE:
Oral bronchodilator and antibacterial for use in the treatment of
respiratory
disease in horses
COMPANY IDENTIFICATION:
Jurox Pty Limited
ADDRESS:
85 Gardiner Street
Rutherford NSW 2320
Australia
CUSTOMER CENTRE:
1800 02 3312
NATIONAL POISONS INFORMATION CENTRE:
13 1126 (Australia-wide)
EMERGENCY TELEPHONE NUMBER:
1800 02 3312 (9 a.m. – 5 p.m.)
SECTION 2: HAZARDS IDENTIFICATION
GHS HAZARD CLASSIFICATIONS:
ACUTE TOXICITY (ORAL) CATEGORY 4
EYE IRRITATION CATEGORY 2A
REPRODUCTIVE TOXICITY CATEGORY 2
RESPIRATORY SENSITIZER CATEGORY 1
SKIN CORROSION/IRRITATION CATEGORY 2
SKIN SENSITIZER CATEGORY 1
STOT - SE (RESP. IRR.) CATEGORY 3
GHS PICTOGRAMS*:
HEALTH HAZARD
EXCLAMATION
MARK
SIGNAL WORD*:
DANGER
HAZARD STATEMENTS*:
Harmful if swallowed.
Causes skin irritation.
May cause an allergic skin reaction.
Causes serious eye irritation.
May cause allergy or asthma symptoms or breathing difficulties if
inhaled.
May cause respiratory irritation.
Suspected of damaging fertility or the unborn child.
PRECAUTIONARY STATEMENTS*:
PREVENTION
Obtain special instructions before use.
Do not handle until all safety precautions have been read and
understood.
Avoid breathing dust.
Wash hands thoroughly after handling.
Do not eat, drink or smoke when using this product.
Use only outdoors or in a well-ventilated area.
Contaminated work clothing should not be allowed out of the workplace.
Wear protective gloves and protective eye protection.
In case of inadequate ventilation wear respiratory protection.
BRONCOPULMIN PLUS TMPS ORAL POWDER
Page 2 of 6
continued
RESPONSE
IF exposed or concerned: Get medical advice.
IF SWALLOWED: Call a POISON CENTRE or doctor if you feel unwell. Rinse
mouth.
IF ON SKIN: Wash with plenty of soap and water. If skin irritation or
rash occurs: Get
medical advice.
Ta

전체 문서 읽기

안전 데이터 시트

WWW.JUROX.COM.AU
Customer Service 1800 023 312
® Registered Trademark of Jurox Pty Ltd
TECHNICAL NOTES
ACTIVE CONSTITUENTS
Clenbuterol hydrochloride 21.44 µg/g
Sulfadiazine 335 mg/g
Trimethoprim 67 mg/g
ACTIONS
Oral bronchodilator and antibacterial for respiratory disease in
horses. Clenbuterol is a sympathomimetic amine that blocks the
β2-receptor sites in the body which include those in the lungs and
uterus. This allows for maximum bronchodilation with increased
pulmonary ventilation and mucociliary clearance without significant
effects on the cardiovascular system. The antibacterial agents
trimethoprim and sulfadiazine, which have a synergistic action,
inhibit the production of folic acid and the conversion of folic acid
to
folinic acid. This stops the bacteria producing purine, RNA and DNA
and thus has a bactericidal effect.
INDICATIONS
Treatment of respiratory disease in horses caused by organisms
susceptible to the trimethoprim/sulfadiazine combination.
Treatment of respiratory conditions characterised by constriction of
the airways including bronchospasm and obstruction resulting
from bacterial and viral infection, bronchitis and bronchopneumonia.
Indicated whenever bronchodilation and antibacterial
protection is desirable.
CONTRAINDICATIONS
NOT TO BE USED in food producing animals.
PRECAUTIONS
Broncopulmin Plus TMPS Oral Powder should not be used in horses during
the last 14 days of gestation as uterine contractions may
be prevented.
BRONCOPULMIN
PLUS TMPS
Oral Powder
WWW.JUROX.COM.AU
Customer Service 1800 023 312
® Registered Trademark of Jurox Pty Ltd
TECHNICAL NOTES
WITHHOLDING PERIODS
NOT TO BE USED in horses intended for human consumption.
INTERACTIONS
Broncopulmin Plus TMPS Oral Powder will potentiate the action of
corticosteroids and antagonise the effects of prostaglandin F2α and
oxytocin. β-adrenergic agents adversely affect the action of
Broncopulmin Plus TMPS Oral Powder. Therefore, concurrent treatment of
horses with these agents is not recommended.
DOSAGE AND ADMINISTRATION
Give 1 level

전체 문서 읽기